Panhellenic Union of Pharmaceutical Industry

Tweet this page
<
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
>
Registration as it was on 24 Feb 2023
How to read and use this data card.
Download this datacard

Overview

WARNING: As this organisation lists one or more EP accredited lobbyists, it may not be probable that its lobbying costs are lower than €10,000.

Lobbying Costs

10,000€ - 24,999€

Financial year: Jan 2022 - Dec 2022

Lobbyists (Full time equivalent)

0.5 Fte (1)

Lobbyists with EP accreditation

0

High-level Commission meetings

2

Lobbying Costs over the years

  • Info

    Panhellenic Union of Pharmaceutical Industry   (PEF)

    EU Transparency Register

    336263411883-56 First registered on 16 Sep 2013

    Goals / Remit

    The PanHellenic Union of Pharmaceutical Industry (PEF) represents domestic pharmaceutical manufacturers in Greece. Our association currently has 47 member companies which develop and produce mainly branded generics, strictly in line with the high quality standards of the EMA and FDA. The Greek pharmaceutical industry has been implementing major investment programs in infrastructure and in process / quality control systems. Within this context, PEFs' main goals and scope of activities at EU level are to develop and maintain a constructive dialogue with EU institutions in order to understand and participate in health policy developments that affect and impact the Greek pharmaceutical industry as well as strengthen the competitiveness of the European pharmaceutical industry as a whole.

    Main EU files targeted

    The Panhellenic Union of Pharmaceutical Industry actively follows legislative files discussed at EU level and follow the legislative process by monitoring the European Commission and European Parliament Committees. In the past, the files that were monitored were SPC, EMA regulations and Horizon funding opportunities. In light of the COVID-19 pandemic and the aftershock effects on healthcare systems around Europe, PEF is actively involved in policy developments regarding the EU pharmaceutical Strategy, the review of the pharmaceutical legislation as well as the IP Action Plan. We try to keep up to date with EU Funding Initiatives and attend as far as possible info days and events supported or organized by the Commission in Brussels or in Greece. Further policies which are of interest to us deal with taxation, employment, research and development and innovation for SMEs.

    Address

    Head Office
    Kifisias Avenue 324-326
    Athens 15451
    GREECE
    EU Office
    Kifisias Avenue 324-326
    Athens 15451
    GREECE

    Website

  • People

    Total lobbyists declared

    1

    Employment timeLobbyists
    50%1

    Lobbyists (Full time equivalent)

    0.5

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 02 Oct 2023

    Name Start date End Date
    Ms Aikaterini Patavou 05 Apr 2017 04 Apr 2018
    Ms Aikaterini Patavou 13 Feb 2016 11 Feb 2017
    Mr Theodoros Tryfon 07 Mar 2015 05 Mar 2016
    Ms Aikaterini Patavou 02 Sep 2014 27 Aug 2015
    Ms Foteini Kosmopoulou 02 Sep 2014 27 Aug 2015
    Ms Aikaterini Patavou 20 Sep 2013 02 Sep 2014

    Complementary Information

    PEF has one person in charge of all EU relations. Ms Patavou is Head of EU Public Affairs and monitors all developments dealing with EU legislations.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Trade and business associations

  • Networking

    Affiliation

    The Panhellenic Union of Pharmaceutical Industry is a member of Medicines for Europe since 2018, the European Association representing generics, biosimilar and value added medicines.

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2022 - Dec 2022

    Lobbying costs for closed financial year

    10,000€ - 24,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    10,000€ - 24,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Other activities

    The PanHellenic Union of Pharmaceutical Industry had engaged in meetings with EU officials both from the European Parliament and the Commission in order to introduce PEF as a reliable source of information for the situation of the pharmaceutical sector in Greece. The executive board of PEF first traveled to Brussels in January and February 2013 to meet with the EU officials and share its concerns and on recent legislative proposals affecting the Greek pharmaceutical manufacturing industry. Each year we conduct outreach programs by traveling to Brussels to conduct meetings and take part of public hearings and events.

  • Meetings

    Meetings

    2 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't publish information about such meetings. All information below comes from European Commission web pages.

    • Date 15 Jul 2022 Location Thessaloniki
      Subject Pharma Strategy
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Attending
      • Margaritis Schinas (Vice-President)
    • Date 08 Oct 2021 Location Athens
      Subject Pharma policies
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Attending
      • Maria Krikou (Cabinet member)
      • Margaritis Schinas (Vice-President)
Download this datacard